Why do so many people in one Italian town live past 100 in excellent health?…
Browsing: Sanford Burnham Prebys
Sanford Burnham Prebys is a renowned nonprofit medical research institute based in La Jolla, California, specializing in fundamental biomedical research aimed at understanding human disease and discovering new treatments. Founded in 1976, the institute focuses on areas such as cancer, neuroscience, immunology, and regenerative medicine. It is known for its collaborative research environment and partnerships with academic, pharmaceutical, and healthcare organizations. Sanford Burnham Prebys combines cutting-edge science with state-of-the-art technologies, including drug discovery and genomics, to translate scientific breakthroughs into innovative therapies for patients worldwide.
New research uncovers new insights into preventing chronic inflammation caused by aging-related zombie-like cells. In…
Nuclear pore complexes regulate critical cell functions and vary in cancer cells. A recent study…
Researchers at Sanford Burnham Prebys have shown that vesicles transporting between brain cells contain more…
PERCEPTION, an AI-based approach predicts cancer treatment responses at single-cell resolution. The method, validated in…
Researchers at Sanford Burnham Prebys have discovered positive connections between certain HIV medications and Alzheimer’s…
Findings identify molecular signaling pathway that could enhance current MS treatments. For decades, scientists have…
Scientists at Stanford University School of Medicine and Sanford Burnham Prebys have demonstrated a new…
A New Study Helps Explain the Anti-Cancer Properties of Mannose Sugar A study reveals new…
By inhibiting one enzyme, scientists from Sanford Burnham Prebys can kill prostate cancer cells when…
A new study from Sanford Burnham Prebys has discovered a drug that can spur liver…
The Researchers Found That Vitronectin Is a Promising Target for Macular Degeneration Francesca Marassi, Ph.D.,…
Findings may have important implications for understanding age-related diseases. Scientists at Sanford Burnham Prebys have…
Targeting the tumor-feeding process of macropinocytosis may lead to breakthrough treatments for pancreatic and other…
Research pinpoints interferon stimulating genes that control SARS-CoV-2 replication. Scientists at Sanford Burnham Prebys have…
Phase 2 clinical trial could begin immediately for clofazimine, an FDA-approved drug on WHO’s List…
Proof-of-concept study shows that stopping the construction of nuclear pore complexes selectively kills cancer cells.…
Multiple drugs improve the activity of remdesivir, a current standard-of-care treatment for COVID-19. A Nature…